We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Island Setting Receives Improved Clinical Laboratory Diagnostics

By LabMedica International staff writers
Posted on 13 Jul 2009
A testing system is helping to improve efficiency in a hospital laboratory on the Isle of Guernsey.

The new system benefits both staff and patients. More...
Previously, different platforms meant multiple blood draws--one serum tube for each of the analyzers, usually three to four per patient-to obtain results as quickly as possible. The new workflow makes the phlebotomist's work easier and means less discomfort for the patient.

Two cobas 6000 analyzers linked to modular preanalytics from Roche (Burgess Hill, UK) are helping the laboratory at Princess Elizabeth Hospital (St Martins, Guernsey BCD) increase efficiency and become more self-sufficient.

"Although [we are] a small isolated lab, we try to do as much as possible ourselves. We were dealing with an escalating number of tests and when the time came to upgrade four aging analyzers in our clinical chemistry department, consolidation seemed an obvious solution," explained Nigel Turner, section head of clinical chemistry at the hospital. With 183 different assays, Roche offers tests on an automated serum work area (SWA) platform, thus providing an ideal solution for the Guernsey laboratory.

As the lab runs a multidisciplinary on-call system, people from various fields including hematology or histology are also required to run the analyzers outside normal core hours. Now, it is just one blood tube, one analyzer.

Roche Diagnostics helps health professionals detect, monitor, and manage the patient's medical condition more effectively.


Related Links:
Roche
Princess Elizabeth Hospital



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.